Symmetry Partners, LLC Dexcom Inc Transaction History
Symmetry Partners, LLC
- $1.47 Billion
- Q4 2025
A detailed history of Symmetry Partners, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Symmetry Partners, LLC holds 15,564 shares of DXCM stock, worth $903,645. This represents 0.06% of its overall portfolio holdings.
Number of Shares
15,564
Previous 15,237
2.15%
Holding current value
$903,645
Previous $1.03 Million
11.9%
% of portfolio
0.06%
Previous 0.11%
Shares
17 transactions
Others Institutions Holding DXCM
# of Institutions
1,084Shares Held
374MCall Options Held
6.86MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA49.1MShares$2.85 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.9MShares$979 Million0.04% of portfolio
-
Baillie Gifford & CO15.6MShares$903 Million0.79% of portfolio
-
Geode Capital Management, LLC Boston, MA11MShares$637 Million0.05% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $22.4B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...